BREAKING NEWS

Pharmaceutical companies

Business

Monsanto rejects Bayer multi-billion dollar bid

Monsanto has rejected an offer worth $62 billion (55.6 billion euros) from Bayer trying to create the world's biggest agricultural supplier.

Monsanto has rejected an offer worth $62 billion (55.6 billion euros) from Bayer trying to create the world's biggest agricultural supplier.

Business

Bayer 'confident' Monsanto offer will be accepted

Germany's Bayer has offered to buy US seeds company Monsanto for $62 billion (55 billion euros) in cash trying to gain the top spot in the fast-consolidating farm supplies industry.

Germany's Bayer has offered to buy US seeds company Monsanto for $62 billion (55 billion euros) in cash trying to gain the top spot in the fast-consolidating farm supplies industry.

News

Pfizer blocks drugs sales for use in lethal injections in US prisons

Drug companies are saying No to death row. The latest pharmaceuticals giant to restrict sales of drugs used in lethal injections to US prisons is

Drug companies are saying No to death row. The latest pharmaceuticals giant to restrict sales of drugs used in lethal injections to US prisons is

Business

Sanofi earnings to be 'stable' despite declining sales

French drugmaker Sanofi has pledged its 2016 earnings will be stable despite declining sales of diabetes and cancer treatments.

French drugmaker Sanofi has pledged its 2016 earnings will be stable despite declining sales of diabetes and cancer treatments.

News

US: Former drug exec goes silent at medicine prices hearing

A former pharmaceuticals chief, who hiked the price of a life-saving medicine by more than five thousand percent, has refused to testify in front of

A former pharmaceuticals chief, who hiked the price of a life-saving medicine by more than five thousand percent, has refused to testify in front of

Business

Millions committed for Ebola vaccine deal

Gavi, an alliance committed to saving lives through vaccination, has put up $5 million for future purchases of a vaccine from US drugmaker Merck Sharp & Dohme to help take it through late-stage clinic

Gavi, an alliance committed to saving lives through vaccination, has put up $5 million for future purchases of a vaccine from US drugmaker Merck Sharp & Dohme to help take it through late-stage clinic

News

Patient dies following clinical drug trial in France

A patient has died after falling into a coma following a medical trial in Rennes, northwest France. Five other people were hospitalised following the

A patient has died after falling into a coma following a medical trial in Rennes, northwest France. Five other people were hospitalised following the

News

Pfizer secures Allergan takeover deal to create new drugs giant

A potent mix of Viagra and Botox is on the cards: their makers have agreed the healthcare sector’s biggest ever takeover deal. The transaction to

A potent mix of Viagra and Botox is on the cards: their makers have agreed the healthcare sector’s biggest ever takeover deal. The transaction to

Business

ISIS Pharmaceuticals 'may look to change name'

It’s worth over seven billion dollars – a Californian biotech company that makes drugs aimed at treating cancer, heart disease and neurological

It’s worth over seven billion dollars – a Californian biotech company that makes drugs aimed at treating cancer, heart disease and neurological

Business

Fear for Greek medicine supplies as 1 billion euros is owed

With an outstanding 1.1. billion euro bill to the pharmaceutical industry, there are fears that Greece could run out of medicine within three

With an outstanding 1.1. billion euro bill to the pharmaceutical industry, there are fears that Greece could run out of medicine within three

Business

Drugmaker Shire in deal to buy US firm

“A significant step in advancing Shire’s strategy to become a leading biotechnology company.” That’s how chief executive Flemming Ornskov described

“A significant step in advancing Shire’s strategy to become a leading biotechnology company.” That’s how chief executive Flemming Ornskov described

Business

Wrinkle free deal as boxtox maker accepts Actavis takeover bid

Botox producer Allergan has accepted a $66 bn takeover bid by Actavis. The deal ends a nine-month pursuit of Allergan by the Canadian company

Botox producer Allergan has accepted a $66 bn takeover bid by Actavis. The deal ends a nine-month pursuit of Allergan by the Canadian company

News

Pfizer and Merck team up to work on anti-cancer treatment

The pharmaceutical companies Merck and Pfizer have signed a deal to develop and market immunology drugs that target cancer. The two are developing

The pharmaceutical companies Merck and Pfizer have signed a deal to develop and market immunology drugs that target cancer. The two are developing

News

Health expert casts doubt over Ebola vaccine for West Africa

A global heath expert has cast doubt over frantic attempts to produce a vaccine to combat Ebola. Anne Roemer-Mahler, from the University of

A global heath expert has cast doubt over frantic attempts to produce a vaccine to combat Ebola. Anne Roemer-Mahler, from the University of

Business

GlaxoSmithKline faces UK probe over bribery allegations

British government investigators have launched a formal criminal probe into drugmaker GlaxoSmithKline. The move follows bribery claims in China, as

British government investigators have launched a formal criminal probe into drugmaker GlaxoSmithKline. The move follows bribery claims in China, as

Business

Drugs giant Pfizer drops AstraZeneca bid

US drugmaker Pfizer has abandoned its multi-billion takeover bid for UK pharmaceutical firm AstraZeneca. The US company said it would not pursue

US drugmaker Pfizer has abandoned its multi-billion takeover bid for UK pharmaceutical firm AstraZeneca. The US company said it would not pursue

Science_technology

Deep cure

Over 99% of the microscopic inhabitants of the world’s seas have still not been scientifically studied, even though many of them might be useful to

Over 99% of the microscopic inhabitants of the world’s seas have still not been scientifically studied, even though many of them might be useful to